System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Rocío Navarro is an expert in Immunology at Hospital Universitario Puerta de Hierro Majadahonda (Spain). Rocío Navarro has authored 32 publications, the most recent in 2025, and is an investigator in 1 clinical trial, 1 of them ongoing. SLR score: 96 (community average: 125). How the SLR is computed.

LeadR Profile

Rocío Navarro Hospital Universitario Puerta de Hierro Majadahonda Spain
96 ScienceLeadR Reputation 96

Unlock

Register Login
Network Map

Immunology

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2015 - 2025
Source: PubMed

Hospital Universitario Puerta de Hierro Majadahonda

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 32

Citations

Citations: 863 1st author: 5 Last author: 2 Unique author: 0

Main journals

Oncoimmunology 4
Cirugía paraguaya 3
PLoS One 3
Sci Rep 2
Adv Sci (Weinh) 1

Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Neutrophil-to-lymphocyte ratio is associated with accelerometer-measured physical activity levels in breast cancer survivors.
PMID 39939471 — exercise, cancer survivors, insulin resistance, insulin, breast neoplasms, lymphocytes, stress, physiological, neoplasms, neutrophils, oxidative stress, biomarkers, hormones, deoxyguanosine, breast, palliative care		Support Care Cancer20251
Dendritic Cell-Mediated Cross-Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS-CoV-2.
PMID 37863812 — infections, dendritic cells, biomedical research, t-lymphocytes, antibodies, neutralizing, sars virus, cross-priming, covid-19, sars-cov-2		Adv Sci (Weinh)20232
A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response.
PMID 37114242 — triple negative breast neoplasms, cells, therapeutics		Oncoimmunology202312
Text mining methods for the characterisation of suicidal thoughts and behaviour.
PMID 36803841 — psychiatry, natural language processing, risk assessment		Psychiatry Res20234
Smartphone-based Ecological Momentary Intervention for secondary prevention of suicidal thoughts and behaviour: protocol for the SmartCrisis V.2.0 randomised clinical trial.
PMID 36127081 — psychiatry, mental health, secondary prevention, smartphone		BMJ Open20229

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 1

By status:

Recruiting 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Smartphone based Ecological Momentary Intervention for Suicide Prevention a Randomised Clinical Trial
NCT04775160 — exercise, safety, emergencies, secondary prevention, smartphone, therapeutics, environment, mentalization, suicide, suicide prevention		N/ARecruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS